Neurocrine Biosciences (NBIX) Price to Sales (2011 - 2026)
Neurocrine Biosciences' Price to Sales was 5.08 in Q2 2026, up 2.4% from 4.96 a year earlier and up 18.8% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Price to Sales (2011 - 2026) Analysis & Trends
For FY2025, Price to Sales at Neurocrine Biosciences came in at 4.96, down 13.8% from FY2024.
- Price to Sales has now declined for three consecutive years.
- In earlier years, Price to Sales was 5.76 in FY2024 (-16.4%), 6.89 in FY2023 (-11.0%), 7.74 in FY2022 (+8.6%) and 7.13 in FY2021 (-16.8%).
- Quarterly Price to Sales has moved between 4.27 (Q1 2026) and 8.50 (Q3 2021) over five years.
- Compared with a year earlier, Price to Sales was higher in two of the last eight quarters, with an average decline of 13.6%.
- The best year-over-year quarter for Price to Sales over five years was Q2 2024 (growth of 19.1%); the worst was Q1 2025 (a decline of 35.2%).
- Per Business Quant data, NBIX's Price to Sales in the three quarters before Q2 2026 was 4.27 (Q1 2026), 4.96 (Q4 2025) and 5.22 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.08 |
| Mar 31, 2026 | 4.27 |
| Dec 31, 2025 | 4.96 |
| Sep 30, 2025 | 5.22 |
| Jun 30, 2025 | 4.96 |
| Mar 31, 2025 | 4.54 |
| Dec 31, 2024 | 5.76 |
| Sep 30, 2024 | 5.20 |
| Jun 30, 2024 | 6.55 |
| Mar 31, 2024 | 7.00 |
| Dec 31, 2023 | 6.89 |
| Sep 30, 2023 | 6.19 |
| Jun 30, 2023 | 5.50 |
| Mar 31, 2023 | 6.17 |
| Dec 31, 2022 | 7.74 |
| Sep 30, 2022 | 7.35 |
| Jun 30, 2022 | 7.19 |
| Mar 31, 2022 | 7.41 |
| Dec 31, 2021 | 7.13 |
| Sep 30, 2021 | 8.50 |
API Access
Neurocrine Biosciences Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();